Aptevo Therapeutics CEO and leadership

Mr. White leads Aptevo Therapeutics as the President and Chief Executive Officer. Prior to this role he was a member of Emergent BioSolutions’ Board of Directors. He is the former Chief Financial Officer of St. Vincent’s Health, a $2.8 billion multi-hospital health system. Mr. White previously served as Executive Director and CFO of Lilly USA, a subsidiary of Eli Lilly and Company, and held other positions in corporate finance at Eli Lilly and Company. He serves on the boards WP Glimcher and OneAmerica Financial Partners Inc., and was previously on the board of of CoLucid Pharmaceuticals, Inc.

Mr. Lamothe leads Finance, Business Development, Investor Relations, and IT. Prior to Aptevo Therapeutics, he was Emergent’s VP Finance, Biosciences Division. Mr. Lamothe assumed this role in 2014 when Emergent concluded the acquisition of Cangene Corporation, where he was Chief Financial Officer. Mr. Lamothe’s business experience is built on a 25+ year career, spanning several industries and both CFO and CEO roles. Prior to Cangene Corporation, Mr. Lamothe was the Chief Financial Officer for Smith Carter Architects and Engineers Incorporated. He also previously served as President and Chief Executive Officer of Kitchen Craft Cabinetry after occupying the position of VP Finance and Chief Financial Officer with that organization. Mr. Lamothe’s other past experience includes serving as Chief Financial Officer for Motor Coach Industries and he has held various roles at James Richardson & Sons, Limited and Ernst & Young LLP.

Jane Gross is a Senior VP/Chief Scientific Ofcr at APTEVO THERAPEUTICS INC. and Board Member at aTyr Pharma Inc. She studied at University of California.

Mr. White leads Aptevo Therapeutics as the President and Chief Executive Officer. Prior to this role he was a member of Emergent BioSolutions’ Board of Directors. He is the former Chief Financial Officer of St. Vincent’s Health, a $2.8 billion multi-hospital health system. Mr. White previously served as Executive Director and CFO of Lilly USA, a subsidiary of Eli Lilly and Company, and held other positions in corporate finance at Eli Lilly and Company. He serves on the boards WP Glimcher and OneAmerica Financial Partners Inc., and was previously on the board of of CoLucid Pharmaceuticals, Inc.

Mr. White leads Aptevo Therapeutics as the President and Chief Executive Officer. Prior to this role he was a member of Emergent BioSolutions’ Board of Directors. He is the former Chief Financial Officer of St. Vincent’s Health, a $2.8 billion multi-hospital health system. Mr. White previously served as Executive Director and CFO of Lilly USA, a subsidiary of Eli Lilly and Company, and held other positions in corporate finance at Eli Lilly and Company. He serves on the boards WP Glimcher and OneAmerica Financial Partners Inc., and was previously on the board of of CoLucid Pharmaceuticals, Inc.